Zobrazeno 1 - 10 of 82 pro vyhledávání: '"V. Lamorgese"'
1
Smoking Prevalence, Knowledge and Perceptions on Tobacco Control Among Healthcare Professionals: A Survey in an Italian Cancer Center
Autor: Pamela Pizzutilo, Michele Montrone, V. Lamorgese, D. Ricci, Vittoria Lapadula, Sandro Cassiano, D. Bafunno, P. Petrillo, A. Zacheo, Annamaria Catino, Alessandra Di Lauro, Gabriella Del Bene, F. Pesola, A. Mastrandrea, Vito Longo, Domenico Galetta, Niccolò Varesano
Publikováno v: Journal of Community Health. 46:597-602
Smoking is recognized as the major cause of lung cancer. Healthcare professionals play an important role in lung cancer prevention policies, as they act as a source of guidance for patients and advocates. The following survey evaluated prevalence, kn
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0cdbeb92931b69be6b9342519e75e0f0
https://doi.org/10.1007/s10900-020-00907-8
Zobrazit plný text záznamu
2
Tobacco control in Europe: A review of campaign strategies for teenagers and adults
Autor: V. Lapadula, Domenico Galetta, Alessandra Di Lauro, D. Ricci, Pamela Pizzutilo, V. Lamorgese, D. Bafunno, Annamaria Catino, A. Mastrandrea, P. Petrillo
Publikováno v: Critical Reviews in Oncology/Hematology. 138:139-147
Background In Europe the prevalence of tobacco use in adults and adolescents is among the highest within the WHO regions. Many resources have been allocated toward the prevention and support for smoking cessation. However, the implemented strategies
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::872f1a4941533e9bb8b9e2e2220aadf6
https://doi.org/10.1016/j.critrevonc.2019.01.022
Zobrazit plný text záznamu
3
Incidence of Infections and Predictors of Mortality During Checkpoint Inhibitor Immunotherapy in Patients With Advanced Lung Cancer: A Retrospective Cohort Study
Autor: Pamela Pizzutilo, Francesco Di Gennaro, Sandro Cassiano, Davide Fiore Bavaro, Annalisa Saracino, V. Lamorgese, F. Pesola, Fabio Signorile, Laura Monno, Ilaria Marech, Annamaria Catino, Gioacchino Angarano, Domenico Galetta
Publikováno v: Open Forum Infectious Diseases
Background Immune checkpoint inhibitors (ICIs) have revolutionized nonsmall cell lung cancer (NSCLC) treatment and significantly increased overall survival of patients. However, the incidence of concurrent infections and their management is still deb
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e95e775bc0b5f4c889a66fed93f8ca1f
http://europepmc.org/articles/PMC8204890
Zobrazit plný text záznamu
4
Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review
Autor: Michele Montrone, F. Pesola, D. Ricci, A. Mastrandrea, V. Lamorgese, P. Petrillo, Vito Longo, Pamela Pizzutilo, Gabriella Del Bene, D. Bafunno, A. Zacheo, Domenico Galetta, Niccolò Varesano, Annamaria Catino, Sandro Cassiano
Publikováno v: J Thorac Dis
This article investigates the effects of tobacco control policies on smoking initiation, cessation and prevalence by examining the papers published in the last 5 years. Twenty-one articles have been selected by two authors and sorted by four types of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319b5a5843757d4703a4858f184d8004
https://pubmed.ncbi.nlm.nih.gov/32802466
Zobrazit plný text záznamu
6
P40.01 Tobacco use in Adolescence and Associated Factors: Products, School, Family, Peers and Movies in Pandemic Period
Autor: Annamaria Catino, F. Pesola, A. Mastrandrea, Pamela Pizzutilo, Michele Montrone, D. Bafunno, A. Zacheo, D. Ricci, V. Lamorgese, S. Cassiano, Vito Longo, I. Marech, P. Petrillo, Domenico Galetta, Niccolò Varesano
Publikováno v: Journal of Thoracic Oncology. 16:S469-S470
Introduction: Tobacco smoking among adolescents is still frequent and stalling in the last decades, so the main purpose of this research is to know if the COVID-19 pandemic had an impact on adolescents' perceptions regarding smoking We investigated:
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::85e87cca9366c409f57ee9f733552eb5
https://doi.org/10.1016/j.jtho.2021.01.810
Zobrazit plný text záznamu
8
EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non–Small-cell Lung Cancer Treated With Immunotherapy
Autor: Pamela Pizzutilo, V. Lamorgese, D. Bafunno, Sara Elena Rebuzzi, Vittoria Lapadula, Arsela Prelaj, Vito Longo, Domenico Galetta, Niccolò Varesano, Massimo Bilancia, F. Pesola, P. Petrillo, Annamaria Catino, A. Mastrandrea, Michele Montrone, Donatella Ricci, Gabriella Del Bene, Flavio Cassano
Publikováno v: Clinical Lung Cancer. 21:365-377.e5
Background Second-line immunotherapy (IO) has shown an overall survival benefit. However, only 18% to 20% of patients with advanced non–small-cell lung cancer (aNSCLC) will respond, with a median progression-free survival (PFS) of 2 to 4 months. Th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b37277141d26eb40b72575710e1076
https://doi.org/10.1016/j.cllc.2019.11.017
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje